190 related articles for article (PubMed ID: 36457)
1. Depletion of brain noradrenaline, but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock.
Mason ST; Corcoran ME
J Pharm Pharmacol; 1979 Apr; 31(4):209-11. PubMed ID: 36457
[TBL] [Abstract][Full Text] [Related]
2. Catecholamines and convulsions.
Mason ST; Corcoran ME
Brain Res; 1979 Jul; 170(3):497-507. PubMed ID: 466425
[TBL] [Abstract][Full Text] [Related]
3. Selective depletion of spinal noradrenaline inhibits post-decapitation convulsions in rats.
Bosland MC; Versteeg DH; de Jong W
Experientia; 1980 Feb; 36(2):224. PubMed ID: 7371766
[TBL] [Abstract][Full Text] [Related]
4. Noradrenaline and ethanol intake in the rat.
Mason ST; Corcoran ME; Fibiger HC
Neurosci Lett; 1979 Apr; 12(1):137-42. PubMed ID: 460697
[TBL] [Abstract][Full Text] [Related]
5. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--III. The effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses.
Green AR; Costain DW; Deakin JF
Neuropharmacology; 1980 Sep; 19(9):907-14. PubMed ID: 7422102
[No Abstract] [Full Text] [Related]
6. Physiological function of descending noradrenaline projections to the spinal cord: role in post-decapitation convulsions.
Mason ST; Fibiger HC
Eur J Pharmacol; 1979 Jul; 57(1):29-34. PubMed ID: 477739
[TBL] [Abstract][Full Text] [Related]
7. Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine.
Stockmeier CA; Larsen BR; Blask DE
J Neurosci Res; 1985; 14(2):279-84. PubMed ID: 3930758
[TBL] [Abstract][Full Text] [Related]
8. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Cooper BR; Breese GR
Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
[No Abstract] [Full Text] [Related]
9. The effects of dorsal bundle injections of 6-hydroxydopamine on avoidance responding in rats.
Fibiger HC; Mason ST
Br J Pharmacol; 1978 Dec; 64(4):601-5. PubMed ID: 728687
[TBL] [Abstract][Full Text] [Related]
10. Effect of central catecholamine alterations by 6-hydroxydopamine on shuttle box avoidance acquistion.
Cooper BR; Breese GR; Howard JL; Grant LD
Physiol Behav; 1972; 9(5):727-31. PubMed ID: 4655165
[No Abstract] [Full Text] [Related]
11. Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour.
Green AR; Deakin JF
Nature; 1980 May; 285(5762):232-3. PubMed ID: 7374776
[TBL] [Abstract][Full Text] [Related]
12. Effect of intracisternal 6-hydroxydopamine on seizure susceptibility in rats.
Browning RA; Maynert EW
Eur J Pharmacol; 1978 Jul; 50(2):97-101. PubMed ID: 679982
[TBL] [Abstract][Full Text] [Related]
13. Facilitation of neocortical kindling by depletion of forebrain noradrenaline.
Altman IM; Corcoran ME
Brain Res; 1983 Jun; 270(1):174-7. PubMed ID: 6409356
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of 6-hydroxydopamine on the clonic convulsions induced by electroshock and decapitation.
Fukuda T; Araki Y; Suenaga N
Neuropharmacology; 1975 Aug; 14(8):579-83. PubMed ID: 1178115
[No Abstract] [Full Text] [Related]
15. Effects of 6-hydroxydopamine-induced catecholamine depletion on shock-precipitated wall climbing of infant rat pups.
Emerich DF; Scalzo FM; Enters EK; Spear NE; Spear LP
Dev Psychobiol; 1985 May; 18(3):215-27. PubMed ID: 3921418
[TBL] [Abstract][Full Text] [Related]
16. Decreased anticonvulsant activity of carbamazepine in 6-hydroxydopamine-treated rats.
Quattrone A; Samanin R
Eur J Pharmacol; 1977 Feb; 41(3):336-6. PubMed ID: 837975
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of intraspinal injection of 6-hydroxydopamine on the clonic convulsion in maximal electroshock seizure.
Oishi R; Suenaga N; Hidaka T; Fukuda T
Brain Res; 1979 Jun; 169(1):189-93. PubMed ID: 455092
[No Abstract] [Full Text] [Related]
18. Forebrain noradrenaline and Metrazol-induced seizures.
Mason ST; Corcoran ME
Life Sci; 1978 Jul; 23(2):167-71. PubMed ID: 682878
[No Abstract] [Full Text] [Related]
19. Central noradrenaline depletion during development and its effect on behaviour.
Brenner E; Mirmiran M; Van Haaren F; Theunisse BC; Feenstra MG; Lamur AA; Van Eden CG; Van der Gugten J
Physiol Behav; 1987; 41(2):163-70. PubMed ID: 2825226
[TBL] [Abstract][Full Text] [Related]
20. Neonatal 6-hydroxydopamine treatment: noradrenaline levels and in vitro 3H-catecholamine synthesis in discrete brain regions of adult rats.
Versteeg DH; van Ree JM; Provoost AP; de Jong W
Life Sci; 1974 Dec; 15(12):2127-34. PubMed ID: 4621009
[No Abstract] [Full Text] [Related]
[Next] [New Search]
